Search Results - "Hem, K.G."

P53 REAL‐WORLD TREATMENT SEQUENCES AND COSTS OF 96 PATIENTS WITH MULTIPLE MYELOMA FROM DIAGNOSIS TO DEATH by Seefat, M.R., Cucchi, D.G.J., Groen, K., Donker, M.L., Hem, K.G., Westerman, M., Gerrits, A.M., Beeker, A., Donk, N., Blommestein, H.M., Zweegman, S.

Get full text

Real-world costs of chronic lymphocytic leukaemia in the Netherlands by Holtzer-Goor, K.M, Bouwmans-Frijters, C.A.M, Schaafsma, M.R, de Weerdt, O, Joosten, P, Posthuma, E.F.M, Wittebol, S, Huijgens, P.C, Mattijssen, E.J.M, Vreugdenhil, G, Visser, H, Peters, W.G, Erjavec, Z, Wijermans, P.W, Daenen, S.M.G.J, van der Hem, K.G, van Oers, M.H.J, Groot, C.A. Uyl-de

“…Abstract We performed a comprehensive cost calculation identifying the main cost drivers of treatment of chronic lymphocytic leukaemia in daily practice. In…”
Get full text

P12 HEALTH-RELATED QUALITY OF LIFE IN FRAIL AND INTERMEDIATE-FIT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH DOSE-ADJUSTED MELPHALAN-PREDNISONE-BORTEZOMIB (MPV) by Seefat, M.R., Stege, C.A.M., Timmers, G.J., Levin, M.D., Hoogendoorn, M., Ypma, P.F., Nijhof, I.S., Velders, G.A., Strobbe, L., Durdu-Rayman, N., Westerman, M., Davidis-van Schoonhoven, M.A., van Kampen, R.J.W., Beeker, A., Koster, A., Dijk, A.C., van de Donk, N.W.C.J., van der Spek, E., Leys, M.B.L., Silbermann, M.H., Groen, K., van der Burg-de Graauw, N.C.H.P., Sinnige, H.A.M., van der Hem, K.G., Levenga, T.H., Bilgin, Y.M., Sonneveld, P., Klein, S.K., Nasserinejad, K., Blommestein, H.M., Cucchi, D.G.J., Lissenberg-Witte, B.I., Zweegman, S.

Get full text

CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma by DOORDUIJN, J. K, VAN DER HOLT, B, STEIJAERT, M. M. C, BUIJT, I, UYL-DE GROOT, C. A, VAN AGTHOVEN, M, MULDER, A. H, SONNEVELD, P, VAN IMHOFF, G. W, VAN DER HEM, K. G, KRAMER, M. H. H, VAN OERS, M. H. J, OSSENKOPPELE, G. J, SCHAAFSMA, M. R, VERDONCK, L. F, VERHOEF, G. E. G

“…To investigate whether the relative dose-intensity of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy could be improved by…”
Get full text

All-trans retinoic acid toxicity by van der Hem, K G, Ossenkoppele, G J

Get more information

High-dose melphalan with re-infusion of unprocessed, G-CFS-primed whole blood is effective and non-toxic therapy in multiple myeloma by Ossenkoppele, G.J., Schuurhuis, G.J., Jonkhoff, A.R., van der Hem, K.G., Legdeur, M.C.J.C., Boot-Bakker, A., Westra, A.H., Dräger, A.M., Huijgens, P.C.

“…In order to shorten the pancytopenic period following high-dose melphalan 140 mg m us2 (HDM) treatment of multiple myeloma patients, we studied the effects of…”
Get full text

Bilateral excision of perinephric fat and fascia (Gerota's fasciectomy) in the treatment of intractable chyluria by Pool, M O, van der Hem, K G, Stel, H V, Luth, W J, Rasker, F M, Gans, R O

“…A case is described of a 59-year-old black man with massive chyluria, probably due to previous infection with Wuchereria bancrofti. Notably, no edema was…”
Get more information